Clinical Trial Update: A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) [Phase 3]

View source ↗

Summary

Phase III study update for JR-141 in Mucopolysaccharidosis II (STARLIGHT) shows the trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Ii

Drugs mentioned

• JR-141

Snippet

Sponsor: JCR Pharmaceuticals Co., Ltd. | Conditions: Mucopolysaccharidosis II | Phase 3 | Status: ACTIVE_NOT_RECRUITING